C4c Proof-of-viability trials

The c4c Proof-of-viability  trials are conducted to test the c4c infrastructure within Europe. National hubs, such as Pedmed-NL, are involved in these studies on national level. The c4c Consortium undertook a competitive selection process of research studies in late 2018/early 2019 to identify clinical trials that investigate high priority medicines in children and young people in Europe.

The Netherlands and Pedmed-NL are involved in both the cASPer-CF and the KD-CAAP studies.